Physicians' Academy for Cardiovascular Education
PCSK9i, changing practice in cardiology: The emerging story

PCSK9i, changing practice in cardiology: The emerging story

EBAC-accredited E-Learning

Online-CME - This course consists of 3 lectures.

During this educational program, PCSK9 inhibiting approaches in treating hypercholesterolemia and in preventing cardiovascular events are disscussed in three lectures.

This course consists of the following lectures:

After watching the videos on PCSK9 inhibtion the learner should be able to:

Expert faculty

Target audience

This educational activity is designed for cardiologists in secondary care and other healthcare professionals with an interest in treating patients with hypercholesterolemia.

CME accreditation

This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit.

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by unrestricted educational grants from Amgen, Sanofi-Regeneron, The Medicines Company and Draupnir Bio.

Online-CME

This is available as accredited online CME for members. Click the button below to enroll:

Enroll

Share this page with your colleagues and friends: